Dose Ranging Study of Lunsekimig Compared With Placebo-control in Adult Participants With Moderate-to-severe Asthma

NCT06102005 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

685

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Lunsekimig
DRUG: Placebo

Sponsor

Sanofi